Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hepatocellular recurrence

Hepatocellular carcinoma (HCC) develops in patients with chronic liver diseases associated with hepatitis B and hepatitis C vims infections with high incidences. Here, an acyclic retinoid has been shown to suppress the posttherapeutic recurrence after interferon-y or glycerrhicin treatment in cirrhotic patients who underwent curative treatment of preceding tumors. The retinoid induced the disappearance of serum lectin-reactive a-fetoprotein (AFP-L3), a tumor marker indicating the presence of unrecognizable tumors in the remnant liver, suggesting a deletion of such minute (pre)malignant clones (clonal deletion). As a molecular mechanism of the clonal deletion, a novel mechanism of... [Pg.1076]

Yokoo H, Kondo T, Okano T, et al. (2007) Protein expression associated with early int-rahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci 98, 665-73. [Pg.152]

Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, Pinna AD. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma key role of immunosuppression. Liver Transplant 2005 11 497-503. [Pg.628]

Benign liver tumours may develop when synthetic C17-a-substituted gonadal steroids (e.g. anabolic steroids usually in high dose, and oral contraceptives) are used for more than 5 years there is also increased risk of hepatocellular carcinoma, although the absolute risk of either complication is very low. These liver tumours are highly vascular and may cause recurrent or acute abdominal pain if they rupture and bleed. [Pg.654]

Sumi, S., Yamashita, Y., Mitsuzaki, K., Yamamoto, H., Urata, J., Nishi-haru, T., Takahashi, M. Power Doppler Sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. Amer. J. Roentgenol. 1999 172 67—71... [Pg.140]

K., Maetani, S., Tobe, T. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992 69 913-919... [Pg.802]

Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., SUmada, K., Hiraguri, M., Koide, N., Adachi, W., Amano, J. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Amer. J. Surg. 2000 191 381-388... [Pg.803]

Iznmi, N., Asahlna, Y., Noguchi, O., Uchlhara, M., Kanazawa, N., Ita-kura, J., Himeno, Y., Miyake, S., Sakai, T., Enomoto, N. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001 91 949-956... [Pg.803]

Kaibori, M., Matsul, Y., Yanagida, H., Yokoigawa, N., Kwon, A.H., Kamlyama, Y. Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin important prognostic factor for recurrent hepatocellular carcinoma. World X Surg. 2004 28 702 - 707... [Pg.803]

Khan, K.N., Yatsuhashi, H., Yamasaki, K., Yamasaki, M., Inoue, O., Koga, M., Yano, M. Prospective analysis of risk factors for early intra-hepatic recurrence of hepatocellular carcinoma following ethanol injection. J. Hepatol. 2000 32 269 - 278... [Pg.803]

Koda, M., Murawaki, Y., Mitsuda, A., Ohyama, K., Horie, Y., Suou, T., Kawasaki, H., Ikawa, S. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000 88 529-537... [Pg.804]

Pompili, M., Rapacdni, G.L., de Luca, F., Caturelll, E., Astone, A., Siena, D.A., Villanl, M.R., Grattagliano, A., Cedrone, A., Gasbarrini, G. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. Cancer 1997 79 1501-1508... [Pg.805]

Chang, Y.C., Dai, Y.C., Chow, N.H. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma a case report and review of oriental cases. Hepato-Gastroenterol. 2003 50 1637-1640... [Pg.805]

Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, et al. Chnicai significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Cancer 1996 77 1781-6. [Pg.1828]

Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000 32 228-32. [Pg.1834]

Marsh JW, Finkelstein SD, Demetris AJ, et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl. 2003 9 664-671. [Pg.57]

Guzman G, Alagiozian-Angelova V, Layden-Almer JE, et al. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol. 2005 18 1498-1503. [Pg.591]

Sugo H, Takamori S, Kojima K, et al. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas. Surg Today. 1999 29 849-855. [Pg.591]

Kumar A, Bal C, Srivastava DN, Thulkar SP, Sharma S, Acharya SK, Duttagupta S (2006) Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Eur J Gastroenterol Hepatol 18 219-223... [Pg.155]

Hughes KS, Rosenstein RB, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG et al (1988) Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 31 1-4 Kainuma O, Asano T, Aoyama H, Shinohara Y (1999) Recurrent hepatocellular carcinoma successfiilly treated with radiofrequency thermal ablation. J Hepat Pancreat Surg 6 190-194... [Pg.177]

Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy long-term results and prognostic factors. Ann Surg Oncol 14(8) 2319-2329 Chuang CH, Chen CY, Tsai HM (2005) Hepatic infarction and hepatic artery pseudoaneurysm with peritoneal bleeding after radiofrequency ablation for hepatoma. Clin Gastroenterol Hepatol 3(11) A23... [Pg.19]

Pereira PL, Trubenbach J, Schenk M et al (2004) Radiofrequency ablation in vivo comparison of four commercially available devices in pig livers. Radiology 232(2) 482-490 Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function implications for a strategy of salvage transplantation. Ann Surg 235(3) 373-382... [Pg.20]

The first clinical trial on MW ablation therapy was published hy Seki et al. (1994). In 18 patients suffering from single unresectable hepatocellular cancer (HCC) smaller than 2 cm, up to 4 MW ablations were performed for treatment. No serious complications were encountered, and no local recurrence was noted in follow-up over 11-22 months. Three patients developed new tumors in sites remote from the treated sites. [Pg.27]

Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K (2004) Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma shortterm recurrences and survival. Oncol Rep 11 105-109... [Pg.121]

O, Koga M, Yano M (2000) Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 32 269-278... [Pg.128]

Choi D, Lim HK, Kim MJ et al (2004) Recurrent hepatocellular carcinoma percutaneous radiofrequency ablation after hepatectomy. Radiology 230 135-141 Chui AK, Rao AR, Island ER et al (2004) Multimodality tumor control and living donor transplantation for unresectable hepatocellular carcinoma. Transplant Proc 36 2287-2288 Dancey JE, Shepherd FA, Paul K et al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahe-patic 90Y-microspheres [In Process Citation]. J Nucl Med 41 1673-1681... [Pg.241]

Mazzaferro V, Battiston C, Perrone S et al (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation a prospective study. Ann Surg 240 900-909 Mondazzi L, Bottelli R, Brambilla G et al (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma a multivariate analysis of prognostic factors. Hepatology 19 1115-1123 Poon RT, Ngan H, Lo CM et al (2000) Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73 109-114... [Pg.242]

Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176 681-688... [Pg.242]

Yamamoto S, Tomita Y, Nakamori S et al. (2003) Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 21(3), 447-452. [Pg.217]

Kumada T, Nakano S, Takeda I, et al (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25 87-92... [Pg.176]

See other pages where Hepatocellular recurrence is mentioned: [Pg.8]    [Pg.123]    [Pg.1251]    [Pg.198]    [Pg.566]    [Pg.348]    [Pg.293]    [Pg.625]    [Pg.599]    [Pg.786]    [Pg.60]    [Pg.70]    [Pg.120]    [Pg.140]    [Pg.154]   


SEARCH



Recurrence

© 2024 chempedia.info